The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, X. C.
Right arrow Articles by Strom, T. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, X. C.
Right arrow Articles by Strom, T. B.
The Journal of Immunology, 1998, 161: 2241-2247.
Copyright © 1998 by The American Association of Immunologists

On Histocompatibility Barriers, Th1 to Th2 Immune Deviation, and the Nature of the Allograft Responses1

Xian Chang Li, Martin S. Zand, Yongsheng Li, Xin Xiao Zheng and Terry B. Strom2

Department of Medicine, Harvard Medical School, and Division of Immunology, Beth Israel Deaconess Medical Center, Boston, MA 02215

In the present study, we have sought to determine the basis for the frequent failure of Th1 to Th2 immune deviation to blunt the severity of allograft rejection, as such immune deviation has proven highly effective in the treatment of several T cell-dependent autoimmune states. Our study demonstrates that treating islet allograft recipient mice with anti-IL-12 mAb is highly effective in producing Th1 to Th2 immune deviation in several model systems (i.e., fully MHC, partially MHC, or multiple minor Ag barriers). Nevertheless, anti-IL-12 failed to prolong the engraftment of fully MHC-mismatched islet allografts. However, anti-IL-12-treated recipients carrying MHC-matched but multiple minor Ag-mismatched allografts experienced prolonged engraftment; allograft tolerance was frequently achieved in the DBA/2J (H-2d) to BALB/c (H-2d) strain combination. In another model, in which the host response was dominated by CD4+ T cells responding to donor allopeptides presented upon host APCs in the context of self MHC class II molecules, anti-IL-12 treatment proved to be extremely potent. Thus, Th1 to Th2 immune deviation produces prolonged engraftment as compared with recipients of MHC-mismatched allografts when rejection is dependent upon indirectly presented allogeneic peptides and a reduced mass of responding alloreactive T cells.




This article has been cited by other articles:


Home page
 J. Leukoc. Biol.Home page
A. E. Anderson, D. J. Swan, B. L. Sayers, R. A. Harry, A. M. Patterson, A. von Delwig, J. H. Robinson, J. D. Isaacs, and C. M. U. Hilkens
LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells
J. Leukoc. Biol., February 1, 2009; 85(2): 243 - 250.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
A. E. Anderson, B. L. Sayers, M. A. Haniffa, D. J. Swan, J. Diboll, X.-N. Wang, J. D. Isaacs, and C. M. U. Hilkens
Differential regulation of naive and memory CD4+ T cells by alternatively activated dendritic cells
J. Leukoc. Biol., July 1, 2008; 84(1): 124 - 133.
[Abstract] [Full Text] [PDF]

Home page
 Phil Trans R Soc BHome page
C. Mariat, A. Sanchez-Fueyo, S. P Alexopoulos, J. Kenny, T. B Strom, and X. X. Zheng
Regulation of T cell dependent immune responses by TIM family members
Phil Trans R Soc B, September 29, 2005; 360(1461): 1681 - 1685.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
X.-Y. Zhu, Y.-H. Zhou, M.-Y. Wang, L.-P. Jin, M.-M. Yuan, and D.-J. Li
Blockade of CD86 Signaling Facilitates a Th2 Bias at the Maternal-Fetal Interface and Expands Peripheral CD4+CD25+ Regulatory T Cells to Rescue Abortion-Prone Fetuses
Biol Reprod, February 1, 2005; 72(2): 338 - 345.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
I. Noci, B. Fuzzi, R. Rizzo, L. Melchiorri, L. Criscuoli, S. Dabizzi, R. Biagiotti, S. Pellegrini, A. Menicucci, and O.R. Baricordi
Embryonic soluble HLA-G as a marker of developmental potential in embryos
Hum. Reprod., January 1, 2005; 20(1): 138 - 146.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
T. B. Strom, L. J. Field, and M. Ruediger
Allogeneic Stem Cell-Derived "Repair Unit" Therapy and the Barriers to Clinical Deployment
J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1133 - 1139.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Seifarth, S. Pop, B. Liu, C. P. Wong, and R. Tisch
More Stringent Conditions of Plasmid DNA Vaccination Are Required to Protect Grafted Versus Endogenous Islets in Nonobese Diabetic Mice
J. Immunol., July 1, 2003; 171(1): 469 - 476.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Sho, A. Yamada, N. Najafian, A. D. Salama, H. Harada, S. E. Sandner, A. Sanchez-Fueyo, X. X. Zheng, T. B. Strom, and M. H. Sayegh
Physiological Mechanisms of Regulating Alloimmunity: Cytokines, CTLA-4, CD25+ Cells, and the Alloreactive T Cell Clone Size
J. Immunol., October 1, 2002; 169(7): 3744 - 3751.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. Abdi, R. N. Smith, L. Makhlouf, N. Najafian, A. D. Luster, H. Auchincloss Jr., and M. H. Sayegh
The Role of CC Chemokine Receptor 5 (CCR5) in Islet Allograft Rejection
Diabetes, August 1, 2002; 51(8): 2489 - 2495.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. J. Baker, M. P. Hernandez-Fuentes, P. A. Brookes, A. N. Chaudhry, H. T. Cook, and R. I. Lechler
Loss of Direct and Maintenance of Indirect Alloresponses in Renal Allograft Recipients: Implications for the Pathogenesis of Chronic Allograft Nephropathy
J. Immunol., December 15, 2001; 167(12): 7199 - 7206.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. M. Thomas, J. L. Contreras, C. A. Smyth, A. Lobashevsky, S. Jenkins, W. J. Hubbard, D. E. Eckhoff, S. Stavrou, D. M. Neville Jr., and F. T. Thomas
Successful Reversal of Streptozotocin-Induced Diabetes With Stable Allogeneic Islet Function in a Preclinical Model of Type 1 Diabetes
Diabetes, June 1, 2001; 50(6): 1227 - 1236.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
D. M. Rothstein, M. F. A. Livak, K. Kishimoto, C. Ariyan, H.-Y. Qian, S. Fecteau, M. Sho, S. Deng, X. X. Zheng, M. H. Sayegh, et al.
Targeting Signal 1 Through CD45RB Synergizes with CD40 Ligand Blockade and Promotes Long Term Engraftment and Tolerance in Stringent Transplant Models
J. Immunol., January 1, 2001; 166(1): 322 - 329.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Zhou, G. L. Szot, Z. Guo, O. Kim, G. He, J. Wang, M. J. Grusby, K. A. Newell, J. R. Thistlethwaite, J. A. Bluestone, et al.
Role of STAT4 and STAT6 Signaling in Allograft Rejection and CTLA4-Ig-Mediated Tolerance
J. Immunol., November 15, 2000; 165(10): 5580 - 5587.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Graca, K. Honey, E. Adams, S. P. Cobbold, and H. Waldmann
Cutting Edge: Anti-CD154 Therapeutic Antibodies Induce Infectious Transplantation Tolerance
J. Immunol., November 1, 2000; 165(9): 4783 - 4786.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Arpinati, C. L. Green, S. Heimfeld, J. E. Heuser, and C. Anasetti
Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells
Blood, April 15, 2000; 95(8): 2484 - 2490.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.